Crinetics Pharmaceuticals, Inc.

Contributing Author

Recent Articles by Crinetics Pharmaceuticals, Inc.

May-15	Crinetics to Present New Research on Paltusotine, Atumelnant and Unmet Needs in Acromegaly Treatment at the American Association of Clinical Endocrinology Annual Meeting 2025 CRNX GlobeNewswire
May-12	Crinetics Pharmaceuticals Announces May 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) CRNX GlobeNewswire
May-08	Crinetics Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Update CRNX GlobeNewswire